Cart (0 Items)
Your cart is currently empty.
View ProductsSize | |
---|---|
Brand | |
Product type | |
Clonality | |
Expression system | |
Applications |
Product name | Trastuzumab Biosimilar - Anti-HER2 mAb - Research Grade |
---|---|
Source | DrugBank DB00072 |
Species | Human |
Expression system | Mammalian cells |
Molecular weight | 145kDa |
Purity | >85% |
Buffer | PBS pH7.5 |
Delivery condition | Blue ice (+4°C) |
Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
Storage condition | 4°C for short term; -20°C for long term |
Brand | ProteoGenix |
Applications | ELISA,WB |
Aliases /Synonyms | Trastuzumab,Trastuzumab,HER2,anti-HER2 |
Reference | PX-TA1005 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | IgG1 |
Clonality | Monoclonal Antibody |
Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research. This product is for research use only.
Immobilized CD340 Recombinant Protein (cat. No. PX-P4121) at 0.5µg/mL (100µL/well) can bind Trastuzumab Biosimilar - Anti-HER2 mAb (cat. No. PX-TA1005) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450 giving an EC50 at 662.9M.
Trastuzumab Biosimilar - Anti-HER2 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Related products
Reviews
Il n’y a pas encore d’avis.